Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Stock analysts at Barrington Research boosted their FY2024 earnings per share (EPS) estimates for Henry Schein in a research note issued to investors on Wednesday, November 6th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $4.75 for the year, up from their prior estimate of $4.72. Barrington Research has a “Outperform” rating and a $82.00 price target on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.32 EPS. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year.
Check Out Our Latest Analysis on HSIC
Henry Schein Stock Performance
Shares of HSIC stock opened at $68.00 on Friday. The firm’s 50 day moving average is $70.51 and its 200 day moving average is $69.75. The stock has a market capitalization of $8.62 billion, a P/E ratio of 25.19, a PEG ratio of 2.08 and a beta of 0.87. Henry Schein has a 12 month low of $62.12 and a 12 month high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46.
Insider Activity
In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.14% of the company’s stock.
Hedge Funds Weigh In On Henry Schein
Several hedge funds and other institutional investors have recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Henry Schein by 11.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company’s stock valued at $2,186,000 after purchasing an additional 2,954 shares during the period. Nordea Investment Management AB increased its stake in shares of Henry Schein by 8.9% in the 1st quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after purchasing an additional 798 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in Henry Schein by 11.0% in the 1st quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company’s stock worth $972,000 after purchasing an additional 1,279 shares during the period. Empirical Finance LLC lifted its position in Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after purchasing an additional 160 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in Henry Schein by 64.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares during the period. 96.62% of the stock is owned by institutional investors.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- Why Are These Companies Considered Blue Chips?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- How to Invest in Small Cap Stocks
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Roth IRA Calculator: Calculate Your Potential Returns
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.